Summary

at San Francisco, California and other locations
study started
estimated completion:

Description

Summary

This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for patients with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in patients with SBS. SBS patients treated and not treated with teduglutide will be enrolled.

Keywords

Short Bowel Syndrome SBS teduglutide Gattex Syndrome

Eligibility

This is an observational registry study. Data will be collected during routine consultations and clinical staff will enter this information into a system at baseline(when a patient consents into the study) and approximately every 6 months following. Each patient will be followed for at least 10 years.

Locations

  • UCSF Benioff Children's Hospital accepting new patients
    San Francisco California 94158 United States
  • Northwest Gastroenterology Clinic, LLC completed
    Portland Oregon 97210 United States
  • Seattle Children's Hospital accepting new patients
    Seattle Washington 98105 United States
  • Gastroenterology Research of San Antonio, LLC accepting new patients
    San Antonio Texas 78229 United States
  • University of Kansas Medical Center Research Institute, Inc. completed
    Kansas City Kansas 66160 United States
  • Saint Luke's Hospital of Kansas City accepting new patients
    Kansas City Missouri 64111 United States
  • Mischer Neuroscience Associates accepting new patients
    Houston Texas 77030 United States
  • Texas Children's Hospital accepting new patients
    Houston Texas 77030 United States
  • The Methodist Hospital accepting new patients
    Houston Texas 77030 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Shire
ID
NCT01990040
Study Type
Observational [Patient Registry]
Last Updated
January 2017